1. Home
  2. NATL vs NVAX Comparison

NATL vs NVAX Comparison

Compare NATL & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NATL
  • NVAX
  • Stock Information
  • Founded
  • NATL 2023
  • NVAX 1987
  • Country
  • NATL United States
  • NVAX United States
  • Employees
  • NATL N/A
  • NVAX N/A
  • Industry
  • NATL
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NATL
  • NVAX Health Care
  • Exchange
  • NATL Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • NATL 2.0B
  • NVAX 2.0B
  • IPO Year
  • NATL N/A
  • NVAX 1995
  • Fundamental
  • Price
  • NATL $27.64
  • NVAX $9.44
  • Analyst Decision
  • NATL Buy
  • NVAX Buy
  • Analyst Count
  • NATL 4
  • NVAX 6
  • Target Price
  • NATL $34.50
  • NVAX $17.83
  • AVG Volume (30 Days)
  • NATL 317.7K
  • NVAX 6.1M
  • Earning Date
  • NATL 11-12-2024
  • NVAX 11-11-2024
  • Dividend Yield
  • NATL N/A
  • NVAX N/A
  • EPS Growth
  • NATL N/A
  • NVAX N/A
  • EPS
  • NATL N/A
  • NVAX N/A
  • Revenue
  • NATL $4,296,000,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • NATL $4.80
  • NVAX N/A
  • Revenue Next Year
  • NATL $3.12
  • NVAX N/A
  • P/E Ratio
  • NATL N/A
  • NVAX N/A
  • Revenue Growth
  • NATL 4.25
  • NVAX N/A
  • 52 Week Low
  • NATL $18.42
  • NVAX $3.53
  • 52 Week High
  • NATL $35.29
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • NATL 51.11
  • NVAX 35.46
  • Support Level
  • NATL $25.70
  • NVAX $9.52
  • Resistance Level
  • NATL $27.69
  • NVAX $10.63
  • Average True Range (ATR)
  • NATL 0.81
  • NVAX 0.48
  • MACD
  • NATL -0.02
  • NVAX -0.07
  • Stochastic Oscillator
  • NATL 63.19
  • NVAX 29.82

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a global customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. They manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications & Technology.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: